MedTrace Logo

AKI Cardiosurgery Diagnostic Study (AKI-CDS)

NCT03632538 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-04-07

No results posted yet for this study

Summary

Acute kidney injury (AKI) is a common and major complication of cardiac surgery. The aim of this study is to evaluate the use of a fragment of proencephalin in plasma and other biomarkers as specific markers for early diagnosis of AKI and the need of renal replacement therapy after cardiac surgery.

Conditions

Interventions

DIAGNOSTIC_TEST

Biomarker ("penKid", adrenomedulin, C-terminal alpha-1 antitrypsin peptide)

Drawing of patients blood for measurement of biomarkers for AKI before and after cardiac surgery (times: 0, 6, 24, 72, 168 hours).

Sponsors & Collaborators

  • University of Rostock

    lead OTHER

Principal Investigators

  • Martin Sauer, MD · University Hospital of Rostock, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-27
Primary Completion
2021-07-31
Completion
2021-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03632538 on ClinicalTrials.gov